Pronađeno: 1-4 / 4 radova

Autori: Bondarenko Igor N

>> Filter: Samo Article i Review

Naslov Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. (Meeting Abstract)
Autori Trukhin Dmytro  Poddubskaya Elena  Andric Zoran G  Bondarenko Igor N  Shevnia Serhii  Zaric Bojan  Bellala Ravishankar  Charoentum Chaiyut  Perez Luis  Bullo Felicitas  Garcia Fernanda 
Info JOURNAL OF CLINICAL ONCOLOGY, (2021), vol. 39 br. 15, Suppl. S, str. -
Projekat mAbxience Research
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC) (Article)
Autori Syrigos Konstantinos  Abert Istvan  Andric Zoran G  Bondarenko Igor N  Dvorkin Mikhail  Galic Kristina  Galiulin Rinat  Kuchava Vladimer  Sriuranpong Virote  Trukhin Dmytro  Zhavrid Edvard  Fu Dongyue  Kassalow Laurent M  Jones Stephanie  Bashir Zahid 
Info BIODRUGS, (2021), vol. 35 br. 4, str. 417-428
Projekat Centus Biotherapeutics
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study. (Meeting Abstract)
Autori Millan Susana  Trukhin Dmytro  Kolesnik Oleksii  Poddubskaya Elena  Andric Zoran G  Bondarenko Igor N  Shevnia Serhii  Bullo Felicitas  Sarnago Cristina 
Info JOURNAL OF CLINICAL ONCOLOGY, (2020), vol. 38 br. 15, Suppl. S, str. -
Projekat mAbxience Research SI
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract)
Autori Fennell DA  Goss GD  Andric Zoran G  Bondarenko Igor N  Zaric Bojan  Ceric Timur  Poddubskaya Elena  Teofilovici F  Guo W  Ramalingam Suresh S 
Info EUROPEAN JOURNAL OF CANCER, (2013), vol. 49 br. , Suppl. 2, str. S801-S801
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX